Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Angelo F. Monti"'
Autor:
Matthias Preusser, Tomáš Kazda, Emilie Le Rhun, Felix Sahm, Marion Smits, Jens Gempt, Johan AF Koekkoek, Angelo F Monti, Marcell Csanadi, János György Pitter, Helen Bulbek, Beatrice Fournier, Caroline Quoilin, Thierry Gorlia, Michael Weller, Giuseppe Minniti, on behalf of the European Organisation for Research, Treatment of Cancer (EORTC) Brain Tumor Group
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Chemotherapy with lomustine is widely considered as standard treatment option for progressive glioblastoma. The value of adding radiotherapy to second-line chemotherapy is not known. Methods EORTC-2227-BTG (LEGATO, NCT05904119) is
Externí odkaz:
https://doaj.org/article/da487c7b1214453fb930ea4fb6b04a3a
Autor:
Catharine H. Clark, Huiqi Yang, Coreen Corning, Joerg Lehmann, Ying Xiao, Mitsuhiro Nakamura, Romaana Mir, Sarah M. Kelly, Ingrid Kristensen, Elizabeth Miles, Martin A. Ebert, Kenton Thompson, Peter Hoskin, Coen W. Hurkmans, Alisha Moore, Angelo F. Monti, Enrico Clementel, Satoshi Ishikura, Nicolaus Andratschke, Jeff M. Michalski, Eduardo Zubizarreta, Stephen F Kry
Publikováno v:
Radiotherapy and Oncology. 150:30-39
Background and purpose The Global Quality Assurance of Radiation Therapy Clinical Trials Harmonization Group (GHG) is a collaborative group of Radiation Therapy Quality Assurance (RTQA) Groups harmonizing and improving RTQA for multi-institutional cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc466c4bcc7964d0297dc9d8fa857c48
https://doi.org/10.1016/j.radonc.2020.05.038
https://doi.org/10.1016/j.radonc.2020.05.038
Autor:
Paige A. Taylor, Joerg Lehmann, Alexis Dimitriadis, Masayori Ishikawa, Mohammad Hussein, Jeff M. Michalski, Rebecca M. Howell, Satoshi Kito, Nicolaus Andratschke, David S Followill, Nick Reynaert, J. Lee, Angelo F. Monti, Jessica Lye, Ying Xiao, Catharine H. Clark, Tomas Kron, K Venables, Stephen F Kry
Publikováno v:
Radiotherapy and Oncology. 161:S738-S739
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::361c5184458616ee87fd8b65a779d7e4
https://doi.org/10.1016/s0167-8140(21)07178-4
https://doi.org/10.1016/s0167-8140(21)07178-4
Autor:
Angelo F. Monti, Joerg Lehmann, Enrico Clementel, Mohammad Hussein, Stephen F Kry, Annette Haworth, Satoshi Ishikura, Mitsuhiro Nakamura, David J. Eaton, Peter B. Greer, Jessica Lye, Catharine H. Clark, Coen W. Hurkmans
Publikováno v:
Radiotherapy and Oncology. 125:398-404
Quality assurance (QA) for clinical trials is important. Lack of compliance can affect trial outcome. Clinical trial QA groups have different methods of dose distribution verification and analysis, all with the ultimate aim of ensuring trial complian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7794ba918459f498d9c16c4d86b641
https://doi.org/10.1016/j.radonc.2017.10.012
https://doi.org/10.1016/j.radonc.2017.10.012
Autor:
Enrico Clementel, Philip Poortmans, Warren Grant, C. Hurkmans, N. Andratschke, Nick Reynaert, Angelo F. Monti, Coreen Corning, J. Willmann
Publikováno v:
Radiotherapy and Oncology. 152:S670-S671
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa57f1fb715c7b11921efd840125ac65
https://doi.org/10.1016/s0167-8140(21)01291-3
https://doi.org/10.1016/s0167-8140(21)01291-3
Autor:
Jeff M. Michalski, Sarah M. Kelly, H. Yang, Coreen Corning, Enrico Clementel, R. Mir, N. Andratschke, Satoshi Ishikura, Eduardo Zubizarreta, Alisha Moore, Angelo F. Monti, C. Hurkmans, Stephen F Kry, Elizabeth Miles, Martin A. Ebert, Kenton Thompson, Peter Hoskin, Ying Xiao, Joerg Lehmann, Mitsuhiro Nakamura, Catharine H. Clark, Ingrid Kristensen
Publikováno v:
Radiotherapy and Oncology. 152:S682-S683
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b2b97f238ab4f75d4a364ce6c1d8a6d
https://doi.org/10.1016/s0167-8140(21)01312-8
https://doi.org/10.1016/s0167-8140(21)01312-8
Autor:
O. Kaidar-Person, C. Hurkmans, A.N. de Abrunhosa Branquinho, C. Corning, F. Dhermain, N. Andratschke, J. Saez, J. Verhoeff, Angelo F. Monti, Enrico Clementel, P. Roth
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 105:E617-E618
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01aa9a4a07938d21a2e24447e7a13134
https://doi.org/10.1016/j.ijrobp.2019.06.1148
https://doi.org/10.1016/j.ijrobp.2019.06.1148
Autor:
M. Tomsej, Vincent Grégoire, Damien C. Weber, Joanna Kazmierska, Angelo F. Monti, Warren Grant, R. Bar-Deroma, Coen W. Hurkmans, Pierre Castadot, Melissa Christiaens, Jens Overgaard, Sandra Collette, Jordi Giralt
Publikováno v:
Christiaens, M, Collette, S, Overgaard, J, Gregoire, V, Kazmierska, J, Castadot, P, Giralt, J, Grant, W, Tomsej, M, Bar-Deroma, R, Monti, A F, Hurkmans, C W & Weber, D C 2017, ' Quality assurance of radiotherapy in the ongoing EORTC 1219-DAHANCA-29 trial for HPV/p16 negative squamous cell carcinoma of the head and neck: Results of the benchmark case procedure ', Radiotherapy & Oncology, vol. 123, no. 3, pp. 424-430 . https://doi.org/10.1016/j.radonc.2017.04.019
BACKGROUND AND PURPOSE:The phase III EORTC 1219-DAHANCA 29 intergroup trial evaluates the influence of nimorazole in patients with locally advanced head and neck cancer when treated with accelerated radiotherapy (RT) in combination with chemotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18ca2d68a7af62bbe303cd1de9cdf71c
https://pure.au.dk/portal/da/publications/quality-assurance-of-radiotherapy-in-the-ongoing-eortc-1219dahanca29-trial-for-hpvp16-negative-squamous-cell-carcinoma-of-the-head-and-neck-results-of-the-benchmark-case-procedure(e8fa34f7-3a51-4e70-8729-10116f0c6904).html
https://pure.au.dk/portal/da/publications/quality-assurance-of-radiotherapy-in-the-ongoing-eortc-1219dahanca29-trial-for-hpvp16-negative-squamous-cell-carcinoma-of-the-head-and-neck-results-of-the-benchmark-case-procedure(e8fa34f7-3a51-4e70-8729-10116f0c6904).html
Publikováno v:
Physica Medica. 29:204-207
Intensity Modulated Radiation Therapy (IMRT) is a complex treatment modality that requires pre-treatment patient-specific quality control (QC) in order to assess a correct treatment delivery. The aim of this work is to investigate pre-treatment patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2448f0adf84611db9975d1b49b2a5e10
https://doi.org/10.1016/j.ejmp.2012.01.002
https://doi.org/10.1016/j.ejmp.2012.01.002
Autor:
Giuseppe Girelli, Tiziana Rancati, Vittorio Vavassori, Loris Menegotti, E. Cagna, Angelo F. Monti, Valeria Casanova Borca, F. Tortoreto, Stefania Delle Canne, Gianni Fellin, Claudio Fiorino, Riccardo Valdagni
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 83:38-45
Purpose To model late fecal incontinence after high-dose prostate cancer radiotherapy (RT) in patients accrued in the AIROPROS (prostate working group of the Italian Association of Radiation Oncology) 0102 trial using different endpoint definitions.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6b884e5a64ee0cb5bdda4daff5e5d68
https://doi.org/10.1016/j.ijrobp.2011.06.1953
https://doi.org/10.1016/j.ijrobp.2011.06.1953